We have located links that may give you full text access.
Risk factors for reduced bone mineral density measurements in milk allergic patients.
Pediatric Allergy and Immunology 2018 August 12
BACKGROUND: Earlier studies noted that young adults with IgE-mediated cow's milk allergy (IgE-CMA) have significantly lower bone mineral density (BMD) than age- and gender-matched controls. We sought to identify additional risk factors contributing to the low BMD in IgE-CMA patients.
METHODS: Post-pubertal (defined by Tanner stage V) IgE-CMA patients (n=78, 16-30-years-old females; 17.5-30-years-old males) were evaluated prospectively for BMD using a DXA scan, serum values of bone turnover factor, and dietary and lifestyle questionnaires. Patients receiving >2 short courses of systemic steroid treatments were excluded.
RESULTS: Abnormal BMD measurements (T or Z-scores < -1.0) of the lumbar vertebrae, femoral neck or hip were noted in 60 patients while normal BMD values were present in 18 patients, despite similarly decreased calcium intakes between the groups (p=0.92). Patients with abnormal BMD were more likely to be asthmatic (p=0.014), have a lower weight z-score (p=0.007), have decreased percent caloric intake derived from fat and increased carbohydrate intake (p=0.01 and p=0.03, respectively), in comparison to normal BMD group. Serum values of bone turnover were similar between the groups. On multivariate regression analysis only asthma significantly (p= 0.006) increased risk for osteopenia and osteoporosis (OR (95 CI) 38.5 (2.8-500). Fitting continuous z-scores into a regression model, both asthma and weight z-score were significant (adjusted r2 =0.272). Asthma was significantly overrepresented in osteopenic and osteoporotic subpopulations while decreased weight only in patients with osteoporosis.
CONCLUSIONS: In the context of a low calcium intake, asthma and weight are independent risk factors for decreased BMD in IgE-CMA patients. This article is protected by copyright. All rights reserved.
METHODS: Post-pubertal (defined by Tanner stage V) IgE-CMA patients (n=78, 16-30-years-old females; 17.5-30-years-old males) were evaluated prospectively for BMD using a DXA scan, serum values of bone turnover factor, and dietary and lifestyle questionnaires. Patients receiving >2 short courses of systemic steroid treatments were excluded.
RESULTS: Abnormal BMD measurements (T or Z-scores < -1.0) of the lumbar vertebrae, femoral neck or hip were noted in 60 patients while normal BMD values were present in 18 patients, despite similarly decreased calcium intakes between the groups (p=0.92). Patients with abnormal BMD were more likely to be asthmatic (p=0.014), have a lower weight z-score (p=0.007), have decreased percent caloric intake derived from fat and increased carbohydrate intake (p=0.01 and p=0.03, respectively), in comparison to normal BMD group. Serum values of bone turnover were similar between the groups. On multivariate regression analysis only asthma significantly (p= 0.006) increased risk for osteopenia and osteoporosis (OR (95 CI) 38.5 (2.8-500). Fitting continuous z-scores into a regression model, both asthma and weight z-score were significant (adjusted r2 =0.272). Asthma was significantly overrepresented in osteopenic and osteoporotic subpopulations while decreased weight only in patients with osteoporosis.
CONCLUSIONS: In the context of a low calcium intake, asthma and weight are independent risk factors for decreased BMD in IgE-CMA patients. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app